Literature DB >> 16437152

Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?

K J McCann, P W M Johnson, F K Stevenson, C H Ottensmeier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16437152     DOI： 10.1038/sj.leu.2404095

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

Review 1.  Germinal centres and B cell lymphomagenesis.

Authors:  Katia Basso; Riccardo Dalla-Favera
Journal:  Nat Rev Immunol       Date:  2015-03       Impact factor: 53.106

2.  CREBBP gene mutations are frequently detected in in situ follicular neoplasia.

Authors:  Janine Schmidt; Joan Enric Ramis-Zaldivar; Irina Bonzheim; Julia Steinhilber; Inga Müller; Andrea Haake; Shan Chi Yu; Mark Raffeld; Falko Fend; Itziar Salaverria; Reiner Siebert; Elaine S Jaffe; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

3.  Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.

Authors:  Janice M Spence; Andrew Abumoussa; John P Spence; W Richard Burack
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

4.  Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells.

Authors:  Jonathan M Irish; Debra K Czerwinski; Garry P Nolan; Ronald Levy
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

5.  IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.

Authors:  Mariette Odabashian; Emanuela Carlotti; Shamzah Araf; Jessica Okosun; Filomena Spada; John G Gribben; Francesco Forconi; Freda K Stevenson; Mariarita Calaminici; Sergey Krysov
Journal:  Blood       Date:  2020-03-12       Impact factor: 22.113

6.  Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites.

Authors:  Emilie Mamessier; Charlotte Drevet; Florence Broussais-Guillaumot; Marie-Laure Mollichella; Sylvain Garciaz; Sandrine Roulland; Maxime Benchetrit; Bertrand Nadel; Luc Xerri
Journal:  Haematologica       Date:  2014-12-19       Impact factor: 9.941

7.  Glycosylation of IgG B cell receptor (IgG BCR) in multiple myeloma: relationship between sialylation and the signal activity of IgG BCR.

Authors:  Vesna Ilić; Nadezda Milosević-Jovcić; Sonja Petrović; Dragana Marković; Gordana Stefanović; Tatjana Ristić
Journal:  Glycoconj J       Date:  2008-01-11       Impact factor: 2.916

8.  Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.

Authors:  Giorgia Chiodin; Joel D Allen; Dean J Bryant; Philip Rock; Enrica A Martino; Beatriz Valle-Argos; Patrick J Duriez; Yasunori Watanabe; Isla Henderson; James S Blachly; Katy J McCann; Jonathan C Strefford; Graham Packham; Teunis B H Geijtenbeek; Carl G Figdor; George W Wright; Louis M Staudt; Richard Burack; Thomas A Bowden; Max Crispin; Freda K Stevenson; Francesco Forconi
Journal:  Blood       Date:  2021-10-28       Impact factor: 25.476

9.  Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.

Authors:  Olivier M Lardinois; Leesa J Deterding; Jacob J Hess; Caroline J Poulton; Candace D Henderson; J Charles Jennette; Patrick H Nachman; Ronald J Falk
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

Review 10.  A Comparison of Immunoglobulin Variable Region N-Linked Glycosylation in Healthy Donors, Autoimmune Disease and Lymphoma.

Authors:  Esther M Vletter; Marvyn T Koning; Hans Ulrich Scherer; Hendrik Veelken; Rene E M Toes
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.